adialpharma.com (ADIL) - Kapitalisasi marang bathi resik

Adial Pharmaceuticals, Inc. - logo grafis emiten ADIL

Capital shortages are hindering the completion of alcoholism treatment trials, while FDA requirements create uncertainty for Adial Pharmaceuticals (ADIL). Nevertheless, Adial Pharmaceuticals (ADIL) is developing a closed-loop treatment system based on AD04 featuring genetically tailored therapy. The share price retrospective with the -0.20 indicator clearly illustrates the asset's price action. Meanwhile, the development of new formulas relies on automated biochemical research, which reduces manual labor and accelerates analytics.

adialpharma.com (ADIL): Rasio rega marang bathi saka 04.07.2022 nganti 29.10.2026

Rincian metrik komprehensif lan analitis Adial Pharmaceuticals Inc. (ADIL)

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega Adial|ADIL - Prakiraan konsensus analis
- indikator kapitalisasi pasar:
Biji pasar Adial Pharmaceuticals, Inc.|ADIL - Nilai Perusahaan
- rincian valuasi buku bisnis:
Nilai Buku saben Saham Adial Pharmaceuticals|ADIL - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku adialpharma.com|ADIL - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Adial Pharmaceuticals|ADIL - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Adial|ADIL - Gunggung utang perusahaan|Rasio utang marang nilai buku Adial Pharmaceuticals, Inc.|ADIL - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Adial Pharmaceuticals|Rasio cepet adialpharma.com
- data bathi resik lan rasio valuasi:
ADIL - Bathi resik perusahaan|Bathi sing dikarepake Adial Pharmaceuticals|ADIL - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Adial|ADIL - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Adial Pharmaceuticals, Inc.|ADIL - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Adial Pharmaceuticals|ADIL - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan adialpharma.com|ADIL - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Adial Pharmaceuticals
Ringkesan analisis perusahaan:adialpharma.com ADIL
Produk mawa merek Adial Pharmaceuticals Inc.

The P/E ratio determines the investment payback period via the company's net income. By analyzing the P/E of a company based on net income, an investor assesses market expectations regarding business growth rates. This metric reflects the capitalization efficiency of current cash flows. For Adial Pharmaceuticals (ADIL), this calculation confirms operational resilience. Optimized component supply chains eliminate downtime, ensuring the stability of the profit embedded in this ratio.

Pesaing wigati

INDV: Nilai perusahaan marang bathi resik|Pangali P/E COLL|CRON: Kapitalisasi marang bathi resik|Pangali P/E CGC (Tweed)|Pangali P/E Canna Cabana HITI|ACB - Rasio rega marang bathi|Nilai perusahaan marang bathi resik ACHV (achievelifesciences.com)|Skye Bioscience (SKYE) - Rasio rega marang bathi|Koefisien rega marang bathi Anebulo Pharmaceuticals Inc|INCR (InterCure Ltd) - Pangali P/E|Pangali P/E Nutriband Corp|Pangali P/E NSRX|igcinc.us - Pangali rega marang bathi|Pangali P/E MIRA (MIRA Pharmaceuticals, Inc.)|Periode bali modal bisnis Flora Growth Corp (FLGC)|IMC - Pangali P/E|ARTL - Pangali P/E|ensysce.com (ENSC) - Rasio rega marang bathi|TTNP (Titan Pharmaceuticals, Inc.) - Rasio rega marang bathi|Koefisien rega marang bathi GNLN|INM: Nilai perusahaan marang bathi resik|Rasio rega marang bathi Akanda Corporation (AKAN)|ENVB: Kapitalisasi marang bathi resik|Pangali P/E BGXX (Bright Green Corporation)|Nilai perusahaan marang bathi resik HPCO